Immunoprotection of Mice against Schistosomiasis Mansoni Using Solubilized Membrane Antigens

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Sulbarán, Guidenn ^a,c   Noya, Oscar ^b   Brito, Beatríz ^c   Ballén, Diana E ^a   Cesari, Italo M ^a,d  

^a Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT WORM N BUTANOL EXTRACT; ALKALINE PHOSPHATASE; ANTISCHISTOSOMAL AGENT; BUTANOL; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PROTEOME; UNCLASSIFIED DRUG; HELMINTH ANTIBODY; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EGG PRODUCTION; ELECTROPHORESIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOMEGALY; HISTOCHEMISTRY; IMMUNITY; IMMUNIZATION; LIVER WEIGHT; MASS SPECTROMETRY; MICROSCOPY; MOUSE; NONHUMAN; PARASITE LOAD; SCHISTOSOMIASIS MANSONI; SEQUENCE ANALYSIS; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; PROCEDURES; SCHISTOSOMA MANSONI; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED C57BL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINATION;

EID: 84879508835     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002254     Document Type: Article

References (74)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systemic review, metanalysis, and stimates of people risk. Lancet Infect Dis 6: 411-425.
2. El Ridi R, Tallima H, (2009) Schistosoma mansoni ex vivo lung-state larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. Vaccine 27: 666-673.
3. Harder A, (2002) Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res 88: 395-397.
4. Alarcón de Noya B, Balzan C, Arteaga C, Cesari I, Noya O, (1999) The last fifteen years of schistosomiasis in Venezuela: features and evolution. Mem Inst Oswaldo Cruz 94: 139-146.
5. Norton AJ, Gower CM, Lamberton PH, Webster BL, Lwambo NJ, Blair L, Fenwick A, Webster JP, (2010) Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania. Am J Trop Med Hyg 83: 951-970.
6. Cioli D, Botros SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, et al. (2004) Determination of ED50 values for praziquantel in praziquantel-resistant and-susceptible Schistosoma mansoni isolates. Int J Parasitol 34: 979-987.
7. Bergquist NR, (1995) Schistosomiasis vaccine development: approaches and prospects. Mem Inst Oswaldo Cruz 90: 221-227.
8. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) A tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840.
9. Abath FG, Werkhauser RC, (1996) The tegument of Schistosoma mansoni: functional and immunological features. Parasite Immunol 18: 15-20.
10. Jones MK, Gobert GN, Zhang L, Sunderland P, Mac Mannus DP, (2004) The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioassays 26: 752-765.
11. Van Hellemond JJ, Retra K, Brouwers JF, van Balkom BW, Yazdanbakhsh M, et al. (2006) Functions of the tegument of schistosomes: clues from the proteome and lipidome. Int J Parasitol 31: 691-699.
12. Sher A, Kusel JR, Perez H, Clegg JA, (1974) Partial isolation of a membrane antigen which induces the formation of antibodies lethal to schistosomes cultured in vitro. Clin Exp Immunol 18: 357-369.
13. Teixeira de Melo T, Michel de Araujo J, Do Valle Durães F, Caliari MV, Oliveira SC, et al. (2010) Immunization with newly transformed Schistosoma mansoni schistosomula tegument elicits tegument damage, reduction in egg and parasite burden. Parasite Immunol 32: 749-759.
14. Durães FV, Carvalho NB, Melo TT, Oliveira SC, Fonseca CT, (2009) IL-12 and TNF-alpha production by dendritic cells stimulated with Schistosoma mansoni schistosomula tegument is TLR4- and MyD88-dependent. Immunol Lett 125: 72-77.
15. Karanja DM, Hightower AW, Colley DG, Mwinzi PN, Galil K, et al. (2002) Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study. Lancet 360: 592-596.
16. Capron A, Capron M, Rivaeau G, (2002) Vaccine developed against schistosomiasis from concepts to clinical trials. British Medical Bulletin 62: 139-148.
17. Linder E, Thors C, (1992) Schistosoma mansoni: praziquantel-induced tegumental lesion exposes actin of surface spines and allows binding of actin depolymerizing factor, gelsolin. Parasitology 105: 71-79.
18. Fallon PG, Mc Neice C, Probert AJ, Doenhoff MJ, (1994) Quantification of praziquantel-induced damage on the surface of adult Schistosoma mansoni worms: estimation of esterase and alkaline phosphatase activity. Parasitol Res 80: 623-625.
19. Joseph S, Jones FM, Walter K, Fulford Aj, Kimani G, et al. (2004) Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. J Infect Dis 15: 835-842.
20. Tallima H, El Ridi R, (2007) Praziquantel binds Schistosoma mansoni adult worm actin. Int J Antimicrob Agents 29: 570-575.
21. Fitzsimmons CM, Joseph S, Jones FM, Reimert CM, Hoffmann KF, et al. (2004) Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E. Infect Immun 72: 4023-4030.
22. Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, et al. (2010) Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni. J Infect Dis 15: 399-405.
23. Cesari IM, Ballen DE, Mendoza L, Matos C, (2005) Detection of Schistosoma mansoni membrane antigens by immunoblot analysis of sera of patients from low-transmission areas. Clin Diagn Lab Immunol 12: 280-286.
24. Cesari IM, Simpson AJ, Evans WH, (1981) Properties of a series of tegumental membrane-bound phosphohydrolase activities of schistosoma mansoni. Biochem J 198: 467-473.
25. Cesari IM, Bouty I, Bout D, De Noya BA, Hoebeke J, (1992) Parasite enzymes as a tool to investigate immune responses. Mem Inst Oswaldo Cruz 87: 55-65.
26. Pujol FH, Cesari IM, (1990) Antigenicity of adult Schistosoma mansoni alkaline phosphatase. Parasite Immunol 12: 189-198.
27. Bradford MM, (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7: 248-254.
28. Smithers SR, Terry RJ, (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55: 695-700.
29. Cheever AW, Lenzi JA, Lenzi HL, Andrade ZA, (2002) Experimental models of Schistosoma mansoni infection. Mem Inst Oswaldo Cruz 97: 917-940.
30. Pellegrino J, Siqueira AF, (1956) A perfusion technic for recovery of Schistosoma mansoni from experimentally infected guinea pigs. Rev Bras Malariol Doencas Trop 8: 589-597.
31. Shuxian L, Guangchen S, Yuxian X, Yang W, McMannus DP, (1995) Immunization of mice with recombinant Sjc 26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine 13: 603-607.
32. Cheever AW, Powers KG, (1968) Counting of Schistosoma mansoni eggs in feces. Comparison of a filtration technique and a dilution technique. J Parasitol 54: 632-633.
33. Cesari IM, Ferrer A, Kombila M, Pichard E, Decam C, et al. (1998) Specificity of the solid phase alkaline phosphatase immunocapture assay for the diagnosis of human Schistosoma mansoni infection. Trans R Soc Trop Med Hyg 92: 38-39.
34. Laemmli UK, (1970) Cleavage of structural proteins during the assembling of the head of bacteriophage T4. Nature 227: 680-684.
35. Towbin H, Staehelin T, Gordon J, (1979) Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci 76: 4350-4354.
36. Noya O, Alarcón de Noya, (1998) The multiple antigen blot assay (MABA): a simple immunoenzymatic technique for simultaneous screening of multiple antigens. Immunol Lett 6: 53-56.
37. Schistosomiasis, Fact Sheet No 115; February 2010. World Health Organization. Available at http://www.who.int/mediacentre/facesheets/fs115/en/index.html. Accessed Oct 5, 2010.
38. Skelly PJ, Wilson AR, (2006) Making sense of the schistosome surface. Adv Parasitol 63: 185-284.
39. Wilson RA, Coulson PS, (2009) Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 25: 423-431.
40. Miki A, Kominami T, Ikehara Y, (1985) pH-dependent conversión of liver-membranous alkaline phosphatase to a serum-soluble form by n-butanol extraction. Biochem Biophys Res Commun 16: 89-95.
41. Cesari IM, Torpier G, Capron A, (1983) Schistosoma mansoni: surface membrane isolation by polycationic beads. Exp Parasitol 56: 119-128.
42. Roberts SM, MacGregor AN, Vojvodic M, Wells E, Crabtree JE, Wilson RA, (1983) Tegument surface membranes of adult Schistosoma mansoni: development of a method for their isolation. Mol Biochem Parasitol 9: 105-127.
43. Payares G, Smithers SR, Evans WH, (1984) Purification and topographical location of tegumental alkaline phosphatase from adult Schistosoma mansoni. Mol Biochem Parasitol 13: 343-360.
44. Bhardwaj R, Skelly PJ, (2011) Characterization of schistosome tegumental alkaline phosphatase (SmAP). PLoS Negl Trop Dis 5: 1011.
45. Rofatto HK, Tararam CA, Borges WC, Wilson RA, Leite LC, Farias LP, (2009) Characterization of phosphodiesterase-5 as a surface protein in the tegument of Schistosoma mansoni. Mol Biochem Parasitol 166: 32-41.
46. Racoosin EL, Davies SJ, Pearce EJ, (1999) Caveoline-like structures in the surface membrane of Schistosoma mansoni. Mol Biochem Parasitol 30: 285-297.
47. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, et al. (2008) Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2: 308.
48. Zhang W, Ahmad G, Torben W, Siddiqui AA, (2010) Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse. Parasite Immunol 32: 252-258.
49. Martins VP, Pinheiro CS, Figueiredo BCP, Assis NRG, Morais SB, et al. (2012) Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection. Clin Develop Immunol 2012doi:10.1155/2012/962538.
50. Lenzi HL, Kimmel E, Schechtman H, Pelajo-Machado M, Romanha WS, et al. (1998) Histoarchitecture of schistosomal granuloma development and involution: morphogenetic and biochemical approaches. Mem Inst Oswaldo Cruz 93: 141-151.
51. Colley DG, Garcia AA, Lambertucci JR, Parra JC, Katz N, et al. (1986) Immune response during human schistosomiasis. XII. Diferential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg 35: 793-802.
52. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse ME, (1997) A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol 19: 255-263.
53. Doenhoff MJ, Modha J, Lambertucci JR, (1988) Anti-schitosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunology 65: 507-510.
54. Braschi S, Wilson AR, (2006) Proteins exposed at the adult Schistosome surface revelaled by biotinylation. Mol Cell Proteomics 5: 347-356.
55. Pujol FH, Liprandi F, Alarcon de Noya B, Matos C, Cesari IM, (1993) Characterization of mouse monoclonal antibodies against common and repeated epitopes of different developmental stages of Schistosoma mansoni. Trop Med Parasitol 44: 289-294.
56. Araujo-Montoya BO, Rofatto HK, Tararam CA, Farias LP, Oliveira KC, et al. (2011) Schistosoma mansoni: molecular characterization of Alkaline Phosphatase and expression patterns across life cycle stages. Exp Parasitol 129: 284-291.
57. Sulbarán GS, Ballen DE, Bermúdez H, Lorenzo M, Noya O, et al. (2010) Detection of the Sm31 antigen in sera of Schistosoma mansoni- infected patients from a low endemic area. Parasite Immunol 32: 20-28.
58. Braschi S, William CB, Wilson AR, (2006) Proteomic analysis of the schistosome tegument and its surface membrane. Mem Inst Oswaldo Cruz 101: 205-212.
59. Losada S, Sabatier L, Hammann P, Guillier C, Matos C, et al. (2011) A combined proteomic and immunologic approach for the analysis of Schistosoma mansoni cercariae and adult worm protein extracts and the detection of one of the vaccine candidates, Sm28GST, from a Venezuelan parasite isolate. Invest Clin 52: 121-139.
60. Hall SL, Braschi S, Truscott M, Mathieson W, Cesari IM, et al. (2011) Insights into blood feeding by schistosomes from a proteomic analysis of worm vomitus. Mol Biochem Parasitol 179: 18-29.
61. Cohen DG, Reinhart B, Castellani L, Norton P, Stirewalt M, (1982) Schistosoma surface spines are "crystals" of actin. J Cell Biol 95: 987-988.
62. Oliveira GC, Kemp WM, (1995) Cloning of two actin genes from Schistosoma mansoni,. Mol Biochem Parasitol 75: 119-122.
63. Hirase A, Hamada T, Itoh TJ, Shimmen T, Sonobe S, (2006) n-Butanol induces depolymerization of microtubules in vivo and in vitro. Plant Cell Physiol 47: 1004-1009.
64. Pearce EJ, Bash PF, Sher A, (1986) Evidence that the reduced surface antigenicity of developing Schistosoma mansoni schistosomula is due to antigen shedding rather than host molecule adquisition. Parasite Immunol 8: 79-94.
65. Soisson LM, Masterson CP, Tom TD, McNally MT, Lowel GH, et al. (1992) Induction of protective immunity in mice using a 62 kDa recombinant fragment of a Schistosoma mansoni surface antigen. J Immunol 1: 3612-3620.
66. Zhang Y, Taylor MG, Bickle QD, (1998) Schistosoma japonicum myosin: cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5. Parasite Immunol 12: 583-594.
67. Andrew P, (1985) Praziquantel: mechanisms of anti-schistosomal activity. Pharmacol Ther 29: 129-156.
68. Richter D, Harn DA, (1993) Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni. Infect Immun 61: 146-54.
69. Reynolds SR, Dahl CE, Harn DA, (1994) T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 1: 193-200.
70. Shoemaker C, Gross A, Gebremichael A, Harn D, (1992) cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase. Proc Natl Acad Sci USA 1: 1842-6.
71. Coulson PS, (1997) The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol 39: 271-336.
72. Coulson PS, Wilson RA, (1988) Examination of the mechanisms of pulmonary phase resistance to Schistosoma mansoni in vaccinated mice. Am J Trop Med Hyg 38: 529-539.
73. Hewitson JP, Hamblin PA, Mountford AP, (2005) Immunity induced by radiation-attenuated schistosome vaccine. Parasite Immunol 27: 271-280.
74. van Balkom BW, van Gestel RA, Brouwers JF, Krijgsveld J, Tielens AG, et al. (2005) Mass spectrometry analysis of the Schistosoma mansoni tegumental sub-proteoma. J proteome Res 4: 958-966.